{
    "company_name": "DIMERIX LIMITED",
    "address": "425 Smith Street, FITZROY, VIC, AUSTRALIA, 3065",
    "summary": "is a clinical stage biopharmaceutical company with a scalable, proprietary platform technology called Receptor-HIT. Incorporated in 2004, Dimerix develops and commercialises patient preferred pharmaceutical products for global markets using our innovative",
    "details": "is a clinical stage biopharmaceutical company with a scalable, proprietary platform technology called Receptor-HIT. Incorporated in 2004, Dimerix develops and commercialises patient preferred pharmaceutical products for global markets using our innovative",
    "website": "http://www.dimerix.com",
    "stock_code": "DXB",
    "links": "['https://dimerix.com/', 'https://dimerix.com/about/', 'https://dimerix.com/about/board-management/', 'https://dimerix.com/about/company-strategy/', 'https://dimerix.com/action3/', 'https://dimerix.com/technology/', 'https://dimerix.com/products/', 'https://dimerix.com/products/dmx-700/', 'https://dimerix.com/products/dmx-200-for-focal-segmental-glomerulosclerosis/', 'https://dimerix.com/partnering/', 'https://investors.dimerix.com/investor-centre/', 'https://investors.dimerix.com/investor-centre/', 'https://investors.dimerix.com/investor-centre/', 'https://investors.dimerix.com/investor-centre/', 'https://investors.dimerix.com/investor-centre/', 'https://dimerix.com/about/board-management/', 'https://investors.dimerix.com/investor-centre/', 'https://dimerix.com/contact/', 'https://dimerix.com/about/', 'https://dimerix.com/about/board-management/', 'https://dimerix.com/about/company-strategy/', 'https://dimerix.com/action3/', 'https://dimerix.com/technology/', 'https://dimerix.com/products/', 'https://dimerix.com/products/dmx-700/', 'https://dimerix.com/products/dmx-200-for-focal-segmental-glomerulosclerosis/', 'https://dimerix.com/partnering/', 'https://investors.dimerix.com/investor-centre/', 'https://investors.dimerix.com/investor-centre/', 'https://investors.dimerix.com/investor-centre/', 'https://investors.dimerix.com/investor-centre/', 'https://investors.dimerix.com/investor-centre/', 'https://dimerix.com/about/board-management/', 'https://investors.dimerix.com/investor-centre/', 'https://dimerix.com/contact/', 'https://dimerix.com/action3/', 'https://dimerix.com/action3/', 'https://dimerix.com/action3/', 'https://dimerix.com/products/', 'https://dimerix.com/products/', 'https://dimerix.com/', 'https://dimerix.com/about/', 'https://dimerix.com/technology/', 'https://dimerix.com/products/', 'https://investors.dimerix.com/investor-centre/', 'https://dimerix.com/contact/', 'tel:1300 813 321', 'mailto:info@dimerix.com', 'http://trueagency.com.au/']",
    "images": "https://dimerix.com/wp-content/themes/true-theme/assets/img/logo.png, https://dimerix.com/wp-content/themes/true-theme/assets/img/logo-white.png, https://dimerix.com/wp-content/uploads/2021/06/Dr-with-patient-355x237.jpg, https://dimerix.com/wp-content/uploads/2021/06/DMX-200-capsules.jpg-355x235.png, https://dimerix.com/wp-content/themes/true-theme/assets/img/common/true-logo.svg",
    "company_logo_link": "https://dimerix.com/wp-content/themes/true-theme/assets/img/logo.png"
}